G71.033 ICD-10-CM Code: Limb girdle muscular dystrophy due to dysferlin dysfunction
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Diseases of the nervous system (G00-G99) / Diseases of myoneural junction and muscle (G70-G73)
G71.033
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceLimb girdle muscular dystrophy due to dysferlin dysfunction
A genetic muscle weakness disorder affecting the hip and shoulder muscles caused by dysferlin protein dysfunction, which helps stabilize muscle cell membranes.

Buddy Insight
Limb girdle muscular dystrophy due to dysferlin dysfunction (LGMD2B/LGMDR2, also known as dysferlinopathy or Miyoshi myopathy) affects muscle membrane repair, leading to progressive proximal and sometimes distal weakness.
CMS-HCC V28
MappedHCC 197
RAF 0.0
CMS-HCC V24
MappedHCC 76
RAF 0.358
ACA/HHS
00
RAF 0
ESRD/PACE
MappedHCC 76
RAF 0.0
RXHCC
00
RAF 0
Code Trumping
Basket needed
Code Book Path
Inclusion Terms
Official- Dysferlinopathy
- LGMD R2 dysferlin-related
- Limb girdle muscular dystrophy type 2B
- Miyoshi Myopathy type 1
Excludes 2
OfficialICD-10-CM does not list Excludes 2 notes for G71.033 in this effective period.
Related Child Codes
Includes
OfficialICD-10-CM does not list Includes notes for G71.033 in this effective period.
Excludes 1
OfficialICD-10-CM does not list Excludes 1 notes for G71.033 in this effective period.
Code First
OfficialICD-10-CM does not list Code First sequencing instructions for G71.033 in this effective period.
Use Additional
OfficialICD-10-CM does not list Use Additional Code instructions for G71.033 in this effective period.
Code Also
OfficialICD-10-CM does not list Code Also instructions for G71.033 in this effective period.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Last updated: FY2026 ICD-10-CM Apr update, Apr 1, 2026 through Sep 30, 2026. CMS-HCC V28 is 100% phased in for payment year 2026.
Is G71.033 an HCC code?
Yes. G71.033 maps to Muscular Dystrophy under the CMS-HCC V28 risk adjustment model (and Muscular Dystrophy under V24).
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for G71.033
For G71.033to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed G71.033 during that encounter, not just copy-forwarded from a problem list.
What This Code Means
G71.033 is the ICD-10-CM diagnosis code for limb girdle muscular dystrophy due to dysferlin dysfunction. A genetic muscle weakness disorder affecting the hip and shoulder muscles caused by dysferlin protein dysfunction, which helps stabilize muscle cell membranes. G71.033 sits in the ICD-10-CM chapter for diseases of the nervous system (g00-g99), within the section covering diseases of myoneural junction and muscle (g70-g73).
Under the CMS-HCC V28 risk adjustment model, G71.033 maps to Muscular Dystrophy (HCC 197) with a community, non-dual, aged base RAF weight of 0.000. Under the older V24 model, G71.033 mapped to the same category but with a base RAF weight of 0.358, V28 recalibrated weights across the entire model. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Verify dysferlin gene mutation or protein deficiency through genetic or muscle biopsy testing. Because G71.033 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for G71.033 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Verify dysferlin gene mutation or protein deficiency through genetic or muscle biopsy testing
- •Note that dysferlin-related disorders can present with variable severity and age of onset
Clinical Significance
Limb girdle muscular dystrophy due to dysferlin dysfunction (LGMD2B/LGMDR2, also known as dysferlinopathy or Miyoshi myopathy) affects muscle membrane repair, leading to progressive proximal and sometimes distal weakness. It is unique among muscular dystrophies in that it can present with distal weakness initially. Accurate coding supports genetic counseling, potential therapeutic trial eligibility, and appropriate risk adjustment.
Documentation Requirements
- ✓Genetic testing confirming DYSF gene mutation or muscle biopsy showing absent/reduced dysferlin
- ✓Clinical presentation: proximal weakness, possible distal involvement, elevated creatine kinase
- ✓Age of onset documentation (typically late teens to young adulthood)
- ✓Functional assessment: ambulatory status, specific muscle groups affected
- ✓Family history and inheritance pattern (autosomal recessive)
- ✓Provider's explicit diagnosis specifying dysferlin dysfunction
Commonly Confused Codes
- •G71.032: Limb girdle muscular dystrophy due to calpain-3 dysfunction has similar proximal weakness but different protein deficiency
- •G71.0340: Limb girdle muscular dystrophy due to sarcoglycan dysfunction involves a different structural protein
- •G71.039: Limb girdle muscular dystrophy, unspecified should not be used when dysferlin mutation is confirmed
- •G71.09: Other specified muscular dystrophies is less specific